/
/
/

Sun Pharma Advanced Research Company Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
₹40 Cr₹1853 Cr₹8 Cr₹8 Cr₹10 Cr₹27 Cr₹15 Cr₹13 Cr₹17 Cr₹17 Cr₹14 Cr₹21 Cr₹24 Cr₹48 Cr
₹24 Cr₹2 Cr₹0₹1 L₹9 Cr₹0₹19 L₹4 L₹2 Cr₹4 Cr₹6 Cr₹8 Cr₹10 Cr₹11 Cr
₹64 Cr₹1855 Cr₹8 Cr₹8 Cr₹19 Cr₹27 Cr₹15 Cr₹13 Cr₹18 Cr₹21 Cr₹20 Cr₹30 Cr₹34 Cr₹58 Cr
₹76 Cr₹82 Cr₹68 Cr₹76 Cr₹64 Cr₹83 Cr₹92 Cr₹119 Cr₹113 Cr₹125 Cr₹120 Cr₹116 Cr₹129 Cr₹140 Cr
-₹10 Cr₹1775 Cr-₹57 Cr-₹66 Cr-₹43 Cr-₹53 Cr-₹74 Cr-₹103 Cr-₹92 Cr-₹101 Cr-₹96 Cr-₹83 Cr-₹92 Cr-₹79 Cr
₹8 Cr₹12 Cr₹9 Cr₹8 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹56 L₹91 L₹26 L₹26 L₹26 L₹21 L
-₹21 Cr₹1761 Cr-₹80 Cr-₹76 Cr-₹52 Cr-₹61 Cr-₹79 Cr-₹107 Cr-₹96 Cr-₹105 Cr-₹100 Cr-₹86 Cr-₹95 Cr-₹82 Cr
-₹21 Cr₹1761 Cr-₹80 Cr-₹76 Cr-₹52 Cr-₹60 Cr-₹80 Cr-₹107 Cr-₹96 Cr-₹106 Cr-₹100 Cr-₹86 Cr-₹95 Cr-₹82 Cr

Share Price Live Stats

Open (₹)197.26
Volume (₹)6.27 L
High (₹)198.09
Upper Circuit215.61
Low (₹)186.99
Lower Circuit176.41
Prev Close196.01
52W High (₹)289.00
Price188.00
52W Low (₹)108.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)6363.87 Cr
Div. Yield (%)0.00
PE Ratio4.02
Debt to Equity0.42
Price to Book2.78
Book Value41.25
EPS (TTM)48.82
Face Value1.00
ROE (%)276.89

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
PFOCUSNSE
SAGILITYNSE
HORIZONINDNSE
SYNGENENSE
INDGNNSE
IGILNSE
NESCONSE
LEAPINDNSE
SPARCNSE
SMARTWORKSNSE
LTP
1W Low
1W High
Market cap (₹)
319+5.45 (1.74%)
307
323.70
24,189Cr
45.6+1.19 (2.68%)
43.47
46.62
21,136Cr
53.59-1.96 (-3.53%)
53.10
56.55
16,043Cr
378.85-5.15 (-1.34%)
375.55
383.80
15,446Cr
570.85-6.5 (-1.13%)
568.30
584.85
13,929Cr
313.1+1.9 (0.61%)
307.05
323.60
13,579Cr
1093+1.8 (0.16%)
1081.60
1132.30
7,770Cr
134.61-6.35 (-4.50%)
132.92
145.31
6,368Cr
188-8.91 (-4.52%)
186.99
198.09
6,364Cr
518.7-16.85 (-3.15%)
517.50
540.35
6,069Cr

Key Highlights of Sun Pharma Advanced Research Company Ltd’s P&L

In 2026-03-31, Sun Pharma Advanced Research Company Ltd reported total revenue of ₹1890.12Cr, compared with ₹73.56Cr in 2025-03-31, reflecting Sun Pharma Advanced Research Company Ltd turnover.

Depreciation was ₹10.21Cr and finance costs were ₹34.13Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹1553.01Cr in 2026-03-31 as compared to ₹-₹342.78Cr in 2025-03-31.

Net Profit (PAT) was ₹1553.2Cr in 2026-03-31 compared with ₹-₹342.51Cr in 2025-03-31.

Earnings per share (EPS) were ₹47.86 in 2026-03-31, compared with ₹-10.55 in 2025-03-31.